Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living with HIV: Week 24 Results from IMPAACT 2014

Ann J. Melvin, Ka Lai Yee, Kathryn P. Gray, Mounika Yedla, Hong Wan, Nicole H. Tobin, Hedy Teppler, Havilland Campbell, Katie McCarthy, Rachel Scheckter, Linda Aurpibul, Pradthana Ounchanum, Supattra Rungmaitree, Hassena Cassim, Elizabeth McFarland, Patricia Flynn, Ellen Cooper, Chelsea Krotje, Ellen Townley, Jack MoyeBrookie M. Best, Justine Beck, Thucuma Sise, Bill G. Kapogiannis, Kathleen George, Patricia Morgan, Yvonne Woolwine-Cunningham, Rebecca Leblanc, Kathleen Trabert, Jeanne Mendell, Carmelita Alvero, Mona Farhad, Sarah Pasyar, Petronella Muresan, Nehali Patel, Adrienne English, Ryan Heince, Sandra Jones, Debra McLaud, Shane Curran Hays, Jennifer Dunn, Kacey Navarro, Amanda Robson, Hilda Ndiwani, Ruth Mathiba, Avy Violari, Nastassja Ramsagar, Nuntisa Chotirosniramit, Chintana Khamrong, Jiraporn Jantong, Tim R. Cressy, Pra Ornsuda Sukrakanchana, Yupawan Thaweesombat, Kanyanee Kaewmamuang, Nirun Vanprapar, Kulkanya Chokephaibulkit, Nantaka Kongstan, Watcharee Lermankul

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)153-161
Number of pages9
JournalJournal of Acquired Immune Deficiency Syndromes
Volume92
Issue number2
DOIs
StatePublished - Feb 1 2023

ASJC Scopus Subject Areas

  • Infectious Diseases
  • Pharmacology (medical)

Keywords

  • HIV-1
  • MK-1439
  • MK-1439A
  • adolescents
  • doravirine

Cite this